Cargando…

Current treatment of low grade gliomas

Low grade gliomas affect predominantly young adults, and have a relatively favorable prognosis compared to grade III and grade IV gliomas. The challenge for an optimal management of these patients is to find the balance between an optimal survival and the preservation of neurological function includ...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Bent, Martin J., Snijders, Tom J., Bromberg, Jacoline E. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458190/ https://www.ncbi.nlm.nih.gov/pubmed/23864911 http://dx.doi.org/10.1007/s12254-012-0014-3

Ejemplares similares

On high‐risk, low‐grade glioma: What distinguishes high from low?
por: Geurts, Marjolein, et al.
Publicado: (2018)

Fatigue in patients with low grade glioma: systematic evaluation of assessment and prevalence
por: van Coevorden-van Loon, Ellen M. P., et al.
Publicado: (2017)

Added Value of Cognition in the Prediction of Survival in Low and High Grade Glioma
por: van Kessel, Emma, et al.
Publicado: (2021)

Perfusion imaging with arterial spin labeling (ASL)–MRI predicts malignant progression in low‑grade (WHO grade II) gliomas
por: Flies, Christina M., et al.
Publicado: (2021)

Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study
por: Kerkhof, M., et al.
Publicado: (2019)

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study
por: Taal, Walter, et al.
Publicado: (2012)

Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study
por: Koekkoek, Johan A F, et al.
Publicado: (2014)

Radiological differences between subtypes of WHO 2016 grade II–III gliomas: a systematic review and meta-analysis
por: van Lent, Djuno I, et al.
Publicado: (2020)

Medical Treatment of Pediatric Low-Grade Glioma
por: Lim, Yeon Jung
Publicado: (2022)

Pediatric Low-Grade Gliomas
por: Collins, Kelly L., et al.
Publicado: (2020)

The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma
por: Van Dijck, Ruben, et al.
Publicado: (2021)

Does early resection of presumed low-grade glioma improve survival? A clinical perspective
por: Wijnenga, Maarten M. J., et al.
Publicado: (2017)

Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective
por: van den Bent, Martin J.
Publicado: (2010)

Memory in low-grade glioma patients treated with radiotherapy or temozolomide: a correlative analysis of EORTC study 22033-26033
por: Klein, Martin, et al.
Publicado: (2020)

Preclinical Models of Low-Grade Gliomas
por: Dasgupta, Pushan, et al.
Publicado: (2023)

Differences in spatial distribution between WHO 2016 low-grade glioma molecular subgroups
por: Wijnenga, Maarten M J, et al.
Publicado: (2019)

Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades
por: Boele, Florien W, et al.
Publicado: (2022)

MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma
por: van der Meulen, Matthijs, et al.
Publicado: (2021)

Current FDA-Approved Therapies for High-Grade Malignant Gliomas
por: Fisher, Jacob P., et al.
Publicado: (2021)

DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets
por: Ozair, Ahmad, et al.
Publicado: (2023)

Therapeutic Interventions in Adult Low-Grade Gliomas
por: Chammas, Majid, et al.
Publicado: (2019)

Clinical Management of Diffuse Low-Grade Gliomas
por: Lombardi, Giuseppe, et al.
Publicado: (2020)

Early Surgery Prolongs Professional Activity in IDH Mutant Low-Grade Glioma Patients: A Policy Change Analysis
por: Robe, Pierre A., et al.
Publicado: (2022)

LONG-TERM EMPLOYMENT STATUS AND THE ASSOCIATION WITH FATIGUE IN PATIENTS WITH GRADE II GLIOMAS
por: VAN COEVORDEN-VAN LOON, Ellen M. P., et al.
Publicado: (2021)

How I treat anaplastic glioma without 1p/19q codeletion
por: Berghoff, Anna, et al.
Publicado: (2019)

Chemotherapy for high-grade gliomas
por: Galanis, E, et al.
Publicado: (2000)

Conventional MRI Criteria to Differentiate Progressive Disease From Treatment-Induced Effects in High-Grade (WHO Grade 3–4) Gliomas
por: Flies, Christina M., et al.
Publicado: (2022)

Pediatric low-grade glioma in the era of molecular diagnostics
por: Ryall, Scott, et al.
Publicado: (2020)

Glioma Stem Cells in Pediatric High-Grade Gliomas: From Current Knowledge to Future Perspectives
por: Da-Veiga, Marc-Antoine, et al.
Publicado: (2022)

Management of Low-Grade Glioma
por: Pouratian, Nader, et al.
Publicado: (2010)

Pseudoprogression in low-grade glioma
por: Slater, Jason M., et al.
Publicado: (2019)

Chemotherapy and diffuse low-grade gliomas: a survey within the European Low-Grade Glioma Network
por: Darlix, Amélie, et al.
Publicado: (2019)

Neurocognitive impairment and patient–proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients
por: Caramanna, Ivan, et al.
Publicado: (2022)

First experiences in treatment of low-grade glioma grade I and II with proton therapy
por: Hauswald, Henrik, et al.
Publicado: (2012)

Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment
por: van Kessel, Emma, et al.
Publicado: (2017)

Profile of nimotuzumab in the treatment of high-grade glioma
por: Yang, Qun-ying, et al.
Publicado: (2015)

Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma
por: Gallus, Marco, et al.
Publicado: (2023)

Clinical Neuropathology Practice News 2-2013: immunohistochemistry pins IDH in glioma – molecular testing procedures under scrutiny
por: Preusser, Matthias, et al.
Publicado: (2013)

Current Status of Neuromodulation-Induced Cortical Prehabilitation and Considerations for Treatment Pathways in Lower-Grade Glioma Surgery
por: Hamer, Ryan P., et al.
Publicado: (2022)

Evaluation of the Hippocampal Normal Tissue Complication Model in a Prospective Cohort of Low Grade Glioma Patients—An Analysis Within the EORTC 22033 Clinical Trial
por: Jaspers, Jaap, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s5q5e0nd29s1s8ul2q8bpumo9b